All Life sciences articles – Page 3
-
News
UBS AM, Reef launch £2.5bn UK life science real estate development strategy
Build-to-core strategy raises initial £400m and secures four sites in London, Oxford and Cambridge
-
News
BentallGreenOak, Mission Street UK life science JV buys 23-acre site
Partnership acquires buy site on Coldham’s Lane in Cambridge for new innovation campus
-
News
BXP expands life science real estate portfolio with $592m purchase
NYSE-listed firm acquires 125 Broadway in Kendall Square in Cambridge, Massachusetts from Biogen
-
News
Railpen buys £29m life-science business park from AEW
UK railways pension scheme acquires Eastpoint Business Park in Oxford
-
News
ESR makes first life science real estate investment in China
ESR and Chinese joint venture partner acquire Zhangjiang NEO facility in Shanghai for RMB268m
-
News
Garbe’s life-science fund acquires property in Netherlands
Open-ended Garbe Science and Technology Real Estate Fund buys property at Einsteinweg 5 in Leiden
-
News
UBS-AM, Reef to invest £900m to develop UK life science campus
Pair acquire 33 acres of land in Stevenage from GSK
-
News
BentallGreenOak, Mission Street UK life science JV plans new project
Joint venture buys 1 Temple Way building to develop 135,000sqft life science facility
-
Special ReportsNet zero and life-science real estate: Easier said than done
Investors are piling into the burgeoning life-science real estate sector, but they might have underestimated the net-zero challenge involved, writes Gary Clark
-
NewsPGGM invests in Asia life science real estate JV with Lendlease
PGGM and Lendlease create partnership to invest S$1bn in innovation and life science-focused real estate
-
News
Barings acquires Boston life sciences building for $132m
The 144,000sqft One Patriots Park sold by Jumbo Capital Incorporated
-
News
GI Partners adds Boston’s 451 D Street building to life science portfolio
Related Fund Management will retain a minority interest in the 479,000sqft life science property
-
News
L&G to invest $500m in US life science real estate venture with Ancora
Legal & General Capital and Ancora create partnership to fund assets across multiple regional US markets
-
News
Actis buys Indian life science real estate services firm Rx Propellant
Actis to invest $200m into a buy and build programme targeting both greenfield and brownfield assets
-
News
Life Science REIT snaps up Oxford Technology Park in £183m deal
London’s junior investment market-listed firm fully deploys IPO proceeds
-
News
Oxford Properties, Novaxia to invest €1bn in French life science properties
Partnership will focus on Paris and explore other emerging markets such as Lyon and Strasbourg
-
News
Life Science REIT makes £85m acquisition in London’s Knowledge Quarter
UK-listed Life Science REIT deploys over 75% IPO proceeds
-
News
Breakthrough Properties makes second UK life-sciences acquisition
Specialist platform launched by Tishman Speyer and Bellco Capital invests in Cambridge
-
News
Tishman Speyer, Bellco JV raises $3bn for life-science real estate fund
Fundraise for Breakthrough Life Science Property Fund surpasses fund’s initial $1.5bn target
-
News
GI Partners raises initial $1.5bn for life science, R&D real estate fund
Fund’s investor base includes public pensions, corporate pensions and financial institutions
